Kristaps Porziņģis

#8 C

Boston Celtics

Status

ACTIVE

Previous game (vs. NYK 5/7)

PTS

REB

AST

BLK

STL

Latest Kristaps Porziņģis news

Porzingis contributed eight points (3-5 FG, 1-1 3Pt, 1-1 FT) and four rebounds over 14 minutes during Wednesday's 91-90 loss to the Knicks in Game 2 of the Eastern Conference Semifinals. Porzingis came off the bench as he continues to deal with an illness, logging fewer than 15 minutes for the second straight game. The star center missed eight games in early March due to illness, and it appears it is still bothering him. Boston now trails 2-0 with the series heading back to New York. While it is likely Porzingis will play in some capacity, it is unclear just how impactful he will be moving forward.

2024-25 Postseason Stats

PTS

REB

AST

BLK

STL

9.7

5.3

0.9

0.6

1.3

1.0

2024-25 Season Stats

PTS

REB

AST

BLK

STL

19.5

6.8

2.1

1.5

0.7

1.3

Career Averages

PTS

REB

AST

BLK

STL

19.6

7.8

1.8

0.7

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2024-25	42	42	28.8	19.5	6.8	2.1	1.5	0.7	1.3	6	2.5	6.0	41.2%	4.1	7.7	53.7%	6.6	13.7	48.3%	3.8	4.7	80.9%	1.6	5.1	2.8	1.6	+173	61.8%
2023-24	57	57	29.6	20.1	7.2	2.0	1.9	0.7	1.6	13	1.9	5.1	37.5%	4.9	8.1	60.6%	6.8	13.2	51.6%	4.5	5.3	85.8%	1.7	5.5	2.7	1.3	+417	64.7%
2022-23	65	65	32.6	23.2	8.4	2.7	1.5	0.9	2.1	20	2.1	5.5	38.5%	5.7	10.2	55.9%	7.8	15.7	49.8%	5.4	6.4	85.1%	1.8	6.6	3.0	1.3	+81	62.7%
2021-22	51	51	29.0	20.2	8.1	2.3	1.6	0.7	1.6	15	1.5	4.9	31.0%	5.4	10.1	53.2%	6.9	15.0	45.9%	4.9	5.6	86.7%	2.0	6.1	2.7	1.5	+33	57.7%
2020-21	43	43	30.8	20.1	8.9	1.6	1.3	0.5	1.2	16	2.3	6.0	37.6%	5.3	9.9	53.6%	7.6	15.9	47.6%	2.7	3.2	85.5%	1.9	7.0	2.7	1.3	+8	58.2%
2019-20	57	57	31.8	20.4	9.5	1.8	2.0	0.7	1.6	25	2.5	7.1	35.2%	4.5	9.3	48.4%	7.0	16.4	42.7%	4.0	5.0	79.9%	1.8	7.7	3.2	1.1	+268	55.1%
2017-18	48	48	32.4	22.7	6.6	1.2	2.4	0.8	1.9	5	1.9	4.8	39.5%	6.3	13.8	45.4%	8.1	18.5	43.9%	4.5	5.7	79.3%	1.3	5.3	2.9	0.6	+15	53.9%
2016-17	66	65	33.3	18.1	7.2	1.5	2.0	0.7	1.8	1	1.7	4.8	35.7%	5.0	10.2	49.3%	6.7	14.9	45.0%	3.0	3.8	78.6%	1.7	5.5	3.7	0.8	+0	54.6%
2015-16	72	72	28.4	14.3	7.3	1.3	1.9	0.7	1.7	1	1.1	3.4	33.3%	4.1	8.9	45.4%	5.2	12.3	42.1%	2.8	3.3	83.8%	1.8	5.5	2.8	0.8	+0	51.8%
Career	501	500	30.8	19.6	7.8	1.8	1.8	0.7	1.7	102	1.9	5.2	36.6%	5.0	9.8	51.2%	6.9	14.9	46.1%	4.0	4.8	82.9%	1.7	6.0	3.0	1.1	+995	57.6%

Career Averages

PTS

REB

AST

BLK

STL

13.2

5.5

1.0

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2024-25	7	6	23.4	9.7	5.3	0.9	0.6	1.3	1.0	1	0.4	2.6	16.7%	2.7	6.4	42.2%	3.1	9.0	34.9%	3.0	4.1	72.4%	2.4	2.9	2.4	0.9	+22	44.9%
2023-24	7	4	23.6	12.3	4.4	1.1	1.6	0.7	0.7	0	1.4	4.1	34.5%	2.6	4.4	58.1%	4.0	8.6	46.7%	2.9	3.1	90.9%	0.6	3.9	2.1	1.6	+39	61.7%
2020-21	7	7	33.3	13.1	5.4	1.3	0.7	1.3	0.4	1	1.1	3.9	29.6%	3.7	6.4	57.8%	4.9	10.3	47.2%	2.3	2.7	84.2%	1.0	4.4	2.7	3.0	-8	57.2%
2019-20	3	3	31.3	23.7	8.7	0.7	1.0	0.0	1.0	1	3.0	5.7	52.9%	4.0	7.7	52.2%	7.0	13.3	52.5%	6.7	7.7	87.0%	1.0	7.7	3.0	0.7	-7	70.8%
Career	24	20	27.3	13.2	5.5	1.0	1.0	1.0	0.8	3	1.3	3.8	33.0%	3.1	6.0	52.1%	4.4	9.8	44.7%	3.2	3.9	82.8%	1.3	4.2	2.5	1.4	+46	57.4%

Regular Season
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/11	CHA	W 130-94	18	11	5	2	0	0	0	7	2	28.6%	4	0	0.0%	11	2	18.2%	6	5	83.3%	1	4	0.0	-3	0	12	40.3%
4/8	NYK	W 119-117	38	34	4	3	1	1	2	13	8	61.5%	6	3	50.0%	19	11	57.9%	6	4	66.7%	0	4	1.5	+0	3	31	78.6%
4/4	PHX	W 123-103	23	15	4	1	1	0	0	5	2	40.0%	7	3	42.9%	12	5	41.7%	4	3	75.0%	0	4	0.0	+16	3	13	54.5%
3/31	MEM	W 117-103	33	19	5	5	0	0	3	5	3	60.0%	9	4	44.4%	14	7	50.0%	3	2	66.7%	3	2	1.7	+29	2	20	62.0%
3/29	SAS	W 121-111	25	11	8	1	2	0	3	4	1	25.0%	7	3	42.9%	11	4	36.4%	2	2	100.0%	3	5	0.3	-3	5	13	46.3%
3/26	PHX	W 132-102	28	30	8	2	2	0	2	5	4	80.0%	10	6	60.0%	15	10	66.7%	8	6	75.0%	4	4	1.0	+27	3	37	81.0%
3/24	SAC	W 113-95	30	16	8	2	2	1	0	4	1	25.0%	9	4	44.4%	13	5	38.5%	6	5	83.3%	1	7	0.0	+6	4	22	51.2%
3/21	UTA	W 121-99	24	27	10	6	0	1	1	5	3	60.0%	10	6	60.0%	15	9	60.0%	6	6	100.0%	4	6	6.0	+3	4	39	76.5%
3/18	BKN	W 104-96	29	25	13	3	3	1	4	4	1	25.0%	9	8	88.9%	13	9	69.2%	8	6	75.0%	2	11	0.8	+12	0	43	75.7%
3/15	BKN	W 115-113	31	24	2	0	1	0	0	7	1	14.3%	9	8	88.9%	16	9	56.3%	6	5	83.3%	0	2	0.0	+13	1	28	64.4%
2/26	DET	L 117-97	25	11	2	1	0	3	2	3	2	66.7%	8	2	25.0%	11	4	36.4%	3	1	33.3%	0	2	0.5	-24	5	3	44.6%
2/23	NYK	W 118-105	33	15	7	2	3	1	1	9	2	22.2%	6	4	66.7%	15	6	40.0%	1	1	100.0%	2	5	2.0	+17	1	21	48.6%
2/20	PHI	W 124-104	25	17	4	1	1	1	2	6	3	50.0%	5	2	40.0%	11	5	45.5%	5	4	80.0%	1	3	0.5	+14	5	16	64.4%
2/12	SAS	W 116-103	37	29	6	1	1	1	5	4	3	75.0%	12	7	58.3%	16	10	62.5%	9	6	66.7%	3	3	0.2	+4	2	26	72.6%
2/10	MIA	W 103-85	32	17	9	2	2	0	1	6	1	16.7%	9	7	77.8%	15	8	53.3%	0	0	0.0%	0	9	2.0	+19	2	21	56.7%
2/6	DAL	L 127-120	26	17	5	1	2	0	2	3	1	33.3%	10	6	60.0%	13	7	53.8%	3	2	66.7%	1	4	0.5	-9	4	17	59.4%
2/4	CLE	W 112-105	34	19	7	2	2	2	2	6	1	16.7%	14	6	42.9%	20	7	35.0%	4	4	100.0%	1	6	1.0	-2	4	20	43.7%
2/2	PHI	W 118-110	31	18	7	3	5	0	0	7	3	42.9%	7	2	28.6%	14	5	35.7%	6	5	83.3%	1	6	0.0	-1	5	22	54.1%
1/31	NOP	W 118-116	30	16	5	6	4	3	1	7	2	28.6%	5	3	60.0%	12	5	41.7%	8	4	50.0%	1	4	6.0	+3	3	25	51.5%
1/29	CHI	W 122-100	33	34	11	3	0	3	1	14	8	57.1%	4	2	50.0%	18	10	55.6%	6	6	100.0%	1	10	3.0	+22	2	50	82.4%
1/27	HOU	L 114-112	25	17	8	2	1	0	1	4	3	75.0%	4	3	75.0%	8	6	75.0%	2	2	100.0%	2	6	2.0	+3	5	22	95.7%
1/25	DAL	W 122-107	28	18	4	5	2	0	1	5	3	60.0%	7	3	42.9%	12	6	50.0%	3	3	100.0%	2	2	5.0	+1	4	23	67.6%
1/23	LAL	L 117-96	27	22	7	2	1	0	1	5	2	40.0%	11	7	63.6%	16	9	56.3%	2	2	100.0%	1	6	2.0	-11	2	24	65.2%
1/20	GSW	W 125-85	22	18	7	2	0	1	0	7	3	42.9%	6	3	50.0%	13	6	46.2%	3	3	100.0%	0	7	0.0	+20	2	22	62.8%
1/17	ORL	W 121-94	23	23	4	1	1	0	0	5	3	60.0%	5	4	80.0%	10	7	70.0%	6	6	100.0%	1	3	0.0	+14	5	26	91.0%
1/15	TOR	L 110-97	34	18	8	3	2	1	3	5	4	80.0%	6	3	50.0%	11	7	63.6%	2	0	0.0%	1	7	1.0	-17	3	23	75.8%
1/12	NOP	W 120-119	33	19	11	1	3	0	1	9	3	33.3%	10	4	40.0%	19	7	36.8%	3	2	66.7%	6	5	1.0	-8	2	19	46.8%
1/10	SAC	L 114-97	29	22	10	0	2	0	0	7	4	57.1%	8	2	25.0%	15	6	40.0%	7	6	85.7%	1	9	0.0	-8	2	26	60.8%
1/7	DEN	W 118-106	34	25	11	3	1	2	1	3	1	33.3%	15	8	53.3%	18	9	50.0%	8	6	75.0%	5	6	3.0	+14	1	35	58.1%
1/5	OKC	L 105-92	29	19	9	1	0	1	4	6	1	16.7%	6	5	83.3%	12	6	50.0%	6	6	100.0%	4	5	0.3	-17	5	20	64.9%
1/3	HOU	W 109-86	27	11	5	2	2	0	1	3	2	66.7%	5	1	20.0%	8	3	37.5%	4	3	75.0%	1	4	2.0	+10	3	15	56.4%
12/25	PHI	L 118-114	13	9	2	3	0	0	0	6	3	50.0%	2	0	0.0%	8	3	37.5%	0	0	0.0%	0	2	0.0	-13	1	9	56.3%
12/23	ORL	L 108-104	36	17	4	0	2	0	1	4	0	0.0%	6	2	33.3%	10	2	20.0%	14	13	92.9%	1	3	0.0	-8	3	17	52.6%
12/21	CHI	W 123-98	29	22	7	2	2	2	1	6	2	33.3%	9	6	66.7%	15	8	53.3%	4	4	100.0%	1	6	2.0	+14	4	27	65.6%
12/19	CHI	L 117-108	35	20	8	0	3	0	0	7	2	28.6%	10	5	50.0%	17	7	41.2%	4	4	100.0%	2	6	0.0	-8	2	20	53.3%
12/15	WAS	W 112-98	11	11	2	2	0	0	1	2	1	50.0%	4	4	100.0%	6	5	83.3%	0	0	0.0%	1	1	2.0	-2	1	15	91.7%
12/12	DET	W 123-99	30	19	8	2	2	1	1	7	2	28.6%	11	6	54.5%	18	8	44.4%	2	1	50.0%	0	8	2.0	+23	0	20	50.3%
12/7	MEM	L 127-121	33	19	8	2	3	1	1	10	3	30.0%	7	3	42.9%	17	6	35.3%	6	4	66.7%	4	4	2.0	+2	5	17	48.4%
12/4	DET	W 130-120	29	26	9	2	2	0	2	7	3	42.9%	10	5	50.0%	17	8	47.1%	8	7	87.5%	4	5	1.0	+16	3	29	63.4%
12/1	CLE	L 115-111	32	21	8	2	0	3	0	7	3	42.9%	10	4	40.0%	17	7	41.2%	4	4	100.0%	1	7	0.0	-5	2	30	56.0%
11/29	CHI	W 138-129	25	21	8	1	0	0	0	5	2	40.0%	6	5	83.3%	11	7	63.6%	7	5	71.4%	0	8	0.0	+7	3	27	74.6%
11/25	LAC	W 126-94	22	16	6	2	2	1	1	6	1	16.7%	6	5	83.3%	12	6	50.0%	4	3	75.0%	1	5	2.0	+3	0	21	58.1%
Regular Season Totals			28.8	19.5	6.8	2.1	1.5	0.7	1.3	6.0	2.5	41.2%	7.7	4.1	53.7%	13.7	6.6	48.3%	4.7	3.8	80.9%	1.6	5.1	1.6	+173	2.8	26.4	61.8%

Postseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
5/7	NYK	L 91-90	13	8	4	0	0	0	1	1	1	100.0%	4	2	50.0%	5	3	60.0%	1	1	100.0%	3	1	0.0	-9	3	7	73.5%
5/5	NYK	L 108-105	12	0	4	1	0	0	1	0	0	0.0%	4	0	0.0%	4	0	0.0%	0	0	0.0%	4	0	1.0	+0	0	1	0.0%
4/29	ORL	W 120-89	21	9	2	1	1	1	0	3	0	0.0%	5	3	60.0%	8	3	37.5%	4	3	75.0%	0	2	0.0	+7	3	9	46.1%
4/27	ORL	W 107-98	22	19	5	1	0	1	1	4	2	50.0%	10	5	50.0%	14	7	50.0%	3	3	100.0%	2	3	1.0	+8	5	17	62.0%
4/25	ORL	L 95-93	34	7	6	1	0	1	2	3	0	0.0%	7	3	42.9%	10	3	30.0%	3	1	33.3%	0	6	0.5	-16	4	7	30.9%
4/23	ORL	W 109-100	33	20	10	0	2	2	0	5	0	0.0%	9	5	55.6%	14	5	35.7%	14	10	71.4%	5	5	0.0	+15	1	27	49.6%
4/20	ORL	W 103-86	25	5	6	2	1	4	2	2	0	0.0%	6	1	16.7%	8	1	12.5%	4	3	75.0%	3	3	1.0	+17	1	10	25.6%
Postseason Totals			23.4	9.7	5.3	0.9	0.6	1.3	1.0	2.6	0.4	16.7%	6.4	2.7	42.2%	9.0	3.1	34.9%	4.1	3.0	72.4%	2.4	2.9	0.9	+22	2.4	13.4	44.9%

Kristaps Porziņģis

#8 C

Status

Previous game (vs. NYK 5/7)

Latest Kristaps Porziņģis news

Limited again in Game 2 loss

2024-25 Postseason Stats

2024-25 Season Stats

Kristaps Porzingis Career Stats

Career Averages

Career Averages

Kristaps Porzingis Season Stats

2024-25

2023-24

2022-23

2021-22

2020-21

2019-20

2017-18

2016-17

2015-16

Previous Game (vs. CHA 4/11)

2024-25 Stats

2024-25 Rebounding

2024-25 Defensive

2024-25 Shooting

2024-25 Advanced

2024-25 Stats

2024-25 Rebounding

2024-25 Defensive

2024-25 Shooting

2024-25 Advanced

Kristaps Porzingis Game Log

2024-25

2023-24

2022-23

2021-22

2020-21

2019-20

2017-18

2016-17

2015-16

Kristaps Porzingis Player Profile

Career History

Kristaps Porzingis Latest News

Limited again in Game 2 loss

Bench role Wednesday

Cleared to play Game 2

Present at shootaround

Expected to suit up Wednesday

Doesn't return in Game 1

Questionable to return Monday

Limited to 21 minutes

Improved performance Sunday

Kristaps Porziņģis

#8 C

Unlock the latest Boston Celtics news — direct to your inbox.

Status

Previous game (vs. NYK 5/7)

Latest Kristaps Porziņģis news Subscribe

2024-25 Postseason Stats

2024-25 Season Stats

Latest Kristaps Porziņģis news